Discover key insights into the PROSPER development programme, including the clinical rationale, study design and endpoints being evaluated in PSP.
congresses & events
AD/PD 2025
Explore the therapeutic potential of OGA inhibition in PSP and learn more about FNP-223, a novel oral investigational treatment being studied as a possible disease-modifying approach.
Related PSP content
-
Medical Education
Explore educational resources designed to support healthcare professionals with up-to-date knowledge on PSP diagnosis, management and care.
-
Clinical Trials & Publications
Scientific updates, study highlights and publications that contribute to advancing knowledge and understanding of PSP.
-
Patient-Focused Initiatives
Discover patient-focused initiatives that raise awareness of PSP and support communication with patients and caregivers through practical resources.
STAY UPDATE
Receive curated updates on clinical research, medical education, key publications and Ferrer initiatives in rare neurological diseases. You can unsubscribe at any time.
